Teva Pharmaceutical Industries is a pharmaceutical company located in Israel, which is part of the Healthcare sector, and is traded under the ticker TEVA on the NYSE exchange.
Teva Pharmaceutical Industries stock last closed at $34.46, down 1.57% from the previous day, and has increased 119.63% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 1.58 percentage points. Teva Pharmaceutical Industries stock is currently +121.61% from its 52-week low of $15.55, and -7.74% from its 52-week high of $37.35.
As of Aug 3, 2026, there are 1.17B shares of TEVA outstanding. The market cap of TEVA is $40.16B. In the past 24 hours, 6.21M TEVA shares were traded.
How to Buy Teva Pharmaceutical Industries Stock
Not sure how to invest in Teva Pharmaceutical Industries stock? Here's how.
Decide where to buy Teva Pharmaceutical Industries stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Teva Pharmaceutical Industries stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit funds into your brokerage account: Select your method of payment and add your information.
Analyze Teva Pharmaceutical Industries stock: The Teva Pharmaceutical Industries ticker symbol is TEVA. Is Teva Pharmaceutical Industries stock a good investment? Should you buy shares of TEVA? How do TEVA's underlying business fundamentals look? Do top analysts think Teva Pharmaceutical Industries is a good buy? Why has TEVA's stock price moved recently? (Hint: Our stock research website can help you figure out if TEVA is a good stock to buy).
Execute your TEVA buy order: Decide if you will purchase TEVA shares at the current market price or use a limit order to purchase TEVA stock at a specific price.
Get notifications regarding your TEVA investment: Create a watchlist to get the latest news on your investment in Teva Pharmaceutical Industries shares.
Step 1: Decide where to buy Teva Pharmaceutical Industries stock
You need a brokerage account in order to access the NYSE market and buy TEVA shares.
A brokerage account is an investment account that allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to world financial markets: From Technology to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal details so you are able to buy TEVA stock today.
Once you have identified the best place to buy Teva Pharmaceutical Industries stock, it's very important to evaluate their stock before you buy, so you actually understand the risk and opportunity.
Teva Pharmaceutical Industries shares data
TEVA Price
$34.46
1w %
10.88%
1y %
119.63%
5y %
247.38%
P/E
54.7x
P/B
5.18x
P/S
2.32x
PEG
N/A
Revenue
$17.32B
Earnings
$706.00M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$40.16B
Next Earnings
N/A
Next Dividend
N/A
Teva Pharmaceutical Industries Overview
WallStreetZen was built to help average investors do more accurate fundamental analysis in minutes instead of hours.
TEVA profit margin has gone up from -1% to 4.1% in the past year.
Failed Financial Due Diligence Checks:
TEVA has a relatively high debt to equity ratio of 4.14.
Total TEVA debt is higher than 5 years ago, relative to shareholder equity.
TEVA earnings of $1.62B is not sufficient to cover its interest payments.
There are more long-term liabilities than short-term assets on the TEVA balance sheet.
There are more short-term liabilities than short-term assets on the TEVA balance sheet.
TEVA's operating cash flow of $1.90B allows it to safely service it's debt of $16.87B.
Do analysts think it's a good time to buy Teva Pharmaceutical Industries stock
Out of 7 Wall Street analysts who give ratings on TEVA, the consensus analyst rating on Teva Pharmaceutical Industries is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Latest TEVA Analyst Recommendations
Jason Gerberry, a top 13% analyst from Bank of America maintains TEVA with a strong buy rating and raises their TEVA price target from $38.00 to $42.00, on Apr 9, 2026.
Bank of America's Jason Gerberry raised their price target on Teva Pharmaceutical Industries (NYSE: TEVA) by 10.5% from $38 to $42 on 2026/04/09. The analyst maintained their Strong Buy rating on the stock.
Teva Pharmaceutical Industries will report its Q1 2026 earnings on 2026/04/29.
Raising their price target in a sector preview of names in their Large-Cap Pharma and Small-to-Mid-Cap biopharma portfolios, Gerberry said they adjusted estimates and price targets for several names in the groups.
Matt Dellatorre, a top 42% analyst from Goldman Sachs maintains TEVA with a strong buy rating and raises their TEVA price target from $36.00 to $45.00, on Feb 9, 2026.
Last year, TEVA revenue was $17.32B. During the last five year, TEVA's revenue has gone up by 1.19% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 7.74%.
No, Teva Pharmaceutical Industries doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your TEVA buy order
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually fine for most investors.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at an exact dollar amount limit, place a limit order.
Click the Open button and your broker will place the order.
If you require more help buying stocks on eToro, click the how to video below:
How much does it cost to buy one Teva Pharmaceutical Industries share?
As of Aug 3, 2026, it costs $34.46 to buy one share of Teva Pharmaceutical Industries stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.29 shares of TEVA.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Is now a good time to buy Teva Pharmaceutical Industries stock?
According to 7 Wall Street analysts who monitor Teva Pharmaceutical Industries, their consensus recommendation is to buy Teva Pharmaceutical Industries stock.
What is the best way to buy Teva Pharmaceutical Industries stock?
One way to place an order for Teva Pharmaceutical Industries stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.